| pubmed-article:18434749 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18434749 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18434749 | lifeskim:mentions | umls-concept:C0019004 | lld:lifeskim |
| pubmed-article:18434749 | lifeskim:mentions | umls-concept:C1524112 | lld:lifeskim |
| pubmed-article:18434749 | lifeskim:mentions | umls-concept:C0342649 | lld:lifeskim |
| pubmed-article:18434749 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:18434749 | lifeskim:mentions | umls-concept:C0718050 | lld:lifeskim |
| pubmed-article:18434749 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
| pubmed-article:18434749 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:18434749 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:18434749 | pubmed:dateCreated | 2008-5-16 | lld:pubmed |
| pubmed-article:18434749 | pubmed:abstractText | Vascular calcification is thought to be associated with a high cardiovascular mortality rate in patients with end-stage renal disease. Control of hyperphosphataemia is important for the treatment of the vascular calcification. The aim of the present study was to evaluate the effects of sevelamer hydrochloride on the progression of aortic calcification in haemodialysis (HD) patients. | lld:pubmed |
| pubmed-article:18434749 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18434749 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18434749 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18434749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18434749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18434749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18434749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18434749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18434749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18434749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18434749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18434749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18434749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18434749 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18434749 | pubmed:issn | 1660-2110 | lld:pubmed |
| pubmed-article:18434749 | pubmed:author | pubmed-author:NittaKosakuK | lld:pubmed |
| pubmed-article:18434749 | pubmed:author | pubmed-author:TakeiTakashiT | lld:pubmed |
| pubmed-article:18434749 | pubmed:author | pubmed-author:UchidaKeikoK | lld:pubmed |
| pubmed-article:18434749 | pubmed:author | pubmed-author:AkibaTakashiT | lld:pubmed |
| pubmed-article:18434749 | pubmed:author | pubmed-author:OtsuboShigeru... | lld:pubmed |
| pubmed-article:18434749 | pubmed:author | pubmed-author:KabayaTakashi... | lld:pubmed |
| pubmed-article:18434749 | pubmed:author | pubmed-author:MatsugamiKeik... | lld:pubmed |
| pubmed-article:18434749 | pubmed:author | pubmed-author:MimuroTomokoT | lld:pubmed |
| pubmed-article:18434749 | pubmed:copyrightInfo | Copyright 2008 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:18434749 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18434749 | pubmed:volume | 108 | lld:pubmed |
| pubmed-article:18434749 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18434749 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18434749 | pubmed:pagination | c278-83 | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:meshHeading | pubmed-meshheading:18434749... | lld:pubmed |
| pubmed-article:18434749 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18434749 | pubmed:articleTitle | Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis. | lld:pubmed |
| pubmed-article:18434749 | pubmed:affiliation | Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan. | lld:pubmed |
| pubmed-article:18434749 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18434749 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18434749 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18434749 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18434749 | lld:pubmed |
